Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Phibro Animal (L, US)  Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals	84		30		21		38
2. Pfizer (XXL, US)  Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals	46		52		63		61
3. AbbVie (XXL, US)  Biotechnology
3. AbbVie (XXL, US)   Biotechnology	46		73		8		34
4. Akorn (M, US)  Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals	38		23		43		20
5. Lannett (M, US)  Pharmaceuticals
5. Lannett (M, US)   Pharmaceuticals	38		43		21		20

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals	19		100		53		66
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	34		78		92		91
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology	46		73		8		34
4. Johnson & Johnson (XXL, US)   Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals	35		66		26		31
5. Pfizer (XXL, US)   Pharmaceuticals
5. Pfizer (XXL, US)   Pharmaceuticals	46		52		63		61
6. Prestige (L, US)   Pharmaceuticals
6. Prestige (L, US)   Pharmaceuticals	4		52		17		3

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	34		78		92		91
2. Merck & Co. (XXL, US)   Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals	20		27		77		28
3. Eli Lilly (XXL, US)   Pharmaceuticals
3. Eli Lilly (XXL, US)   Pharmaceuticals	18		28		68		25
4. Pfizer (XXL, US)   Pharmaceuticals
4. Pfizer (XXL, US)   Pharmaceuticals	46		52		63		61
5. Supernus Pharma (M, US)   Pharmaceuticals
5. Supernus Pharma (M, US)   Pharmaceuticals	19		100		53		66

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	34		78		92		91
2. Supernus Pharma (M, US)   Pharmaceuticals
2. Supernus Pharma (M, US)   Pharmaceuticals	19		100		53		66
3. Pfizer (XXL, US)   Pharmaceuticals
3. Pfizer (XXL, US)   Pharmaceuticals	46		52		63		61
4. Phibro Animal (L, US)   Pharmaceuticals
4. Phibro Animal (L, US)   Pharmaceuticals	84		30		21		38
5. AbbVie (XXL, US)   Biotechnology
5. AbbVie (XXL, US)   Biotechnology	46		73		8		34

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from April 28, 2017.